Search Results
DDx Strength: Weak
efalizumab, Rash or multiple lesions, 50-59 year old Female

Edit Findings
Seborrheic keratosisSeborrheic keratosis
Subacute cutaneous lupus erythematosusSubacute cutaneous lupus erythematosus
AngioedemaAngioedema
Drug-induced hepatotoxicity
Drug-induced lupus erythematosus
ErythrodermaErythroderma
Pruritus without rashPruritus without rash
Ulcerative colitis
Cytomegalovirus infectionCytomegalovirus infection
Diffuse large B-cell lymphoma
Immune thrombocytopenic purpuraImmune thrombocytopenic purpura
Lymphomatoid papulosisLymphomatoid papulosis
Thrombotic thrombocytopenic purpuraThrombotic thrombocytopenic purpura
Acquired pancytopeniaAcquired pancytopenia
Eczematous drug eruption
Bullous pemphigoidBullous pemphigoid
Exanthematous drug eruptionExanthematous drug eruption
PsoriasisPsoriasis
Drug-induced non-palpable purpuraDrug-induced non-palpable purpura
Drug-induced hypersensitivity syndromeDrug-induced hypersensitivity syndrome
Serum sickness-like reactionSerum sickness-like reaction
Drug-induced diarrhea
Drug-induced nausea or vomiting
Migraine headache
Sensorineural deafness
Transverse myelitis
Cervical cancer
Drug-induced arthralgia
Drug-induced fever
Drug-induced headache
Drug-induced myopathies
HypertrichosisHypertrichosis
Aseptic meningitis
Autoimmune hepatitis
Bronchiolitis obliteransBronchiolitis obliterans
Drug-induced leukocytosis
Drug-induced weakness
Hemolytic anemia
LymphomaLymphoma
Progressive multifocal leukoencephalopathy
Acute inflammatory demyelinating polyneuropathy
Drug-induced anemia